From the Publisher:     

     This completely revised 3rd Edition delivers up-to-date coverage of the most recent developments in technology, instrumentation, and radiopharmaceuticals—and now it’s in full color! Internationally recognized experts in the field discuss the full range of nuclear cardiology applications, helping readers gain a better perspective on the current and future use of radionuclides in imaging diagnosis of the heart.

     Key Features:

• Features the contributions of top international experts.
• Comprehensively covers radiopharmaceuticals, instrumentation, tracer kinetics, perfusion imaging, metabolic imaging, and more!

     New to this Edition:

• Provides new discussions of disease and gender-specific issues.
• Includes a new Mini Atlas of Case Presentations, with highly illustrated coverage of all modalities.
• Features a new section, New Molecular Approaches, with 5 new chapters: Angiogenesis * Annexin * Vascular Imaging/Detection * Gene Product Imaging * and Imaging Inflammatory Approaches
• Delivers 2 new chapters on instrumentation: Attenuation/Scatter Coorection: Physics Aspects and Dynamic Cardia SPECT.
• Employs a bold new full-color format throughout.

Table of Contents:

Section I:  Radiopharmaceuticals/ Tracer Kinetics

Chapter 1.     Overview of Kinetics and Modeling

Chapter 2.     Kinetics on a Cellular Level

Chapter 3.     Role of Intact Biological Models for Evaluation of Radiotracers

Section II:  Instrumentation

Chapter 4.     Single-Photon Emission Computed Tomography Processing, Quantification, and Display

Chapter 5.     Single-Photon Emission Computed Tomography Artifacts

Chapter 6.     Attenuation/Scatter/Resolution Correction:  Physics Aspects

Chapter 7.     Attenuation/Scatter Correction:  Clinical Aspects

Chapter 8.     Dynamic Cardiac Single-Photon Emission Computed Tomography Using Fast Data Acquistion Systems

Chapter 9.     The New Generation Positron Emission Tomography/Computed Tomography Scanners:  Implications for Cardiac Imaging

Chapter 10.   State of the Art Instrumentation for Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in Small Animals

Section III:  Ventricular Function

Chapter 11.   Cardiac Performance

Chapter 12.   Regional and Global Ventricular Function and Volumes from Single-Photon Emission Computed Tomography Perfusion Imaging

Section IV:  Perfusion Imaging

Chapter 13.   Coronary Artery Disease:  Exercise Stress

Chapter 14.   Coronary Artery Disease Detection:  Pharmacologic Stress

Chapter 15.   Prognostic Applications of Myocardial Perfusion Imaging:  Exercise Stress

Chapter 16.   Prognostic Value of Pharmacologic Stress Myocardial Perfusion Scintigraphy and Its Use in Risk Stratification

Chapter 17.   Myocardial Perfusion Imaging:  Using Nonradionuclide Techniques

Chapter 18.   Cost Effectiveness of Myocardial Perfusion Single-Photon Emission Computed Tomography

Section V:  Disease/Gender-Specific Issues

Chapter 19.   Imaging in Women

Chapter 20.   Imaging for Preoperative Risk Stratification

Chapter 21.   Nuclear Imaging in Patients with a History of Coronary Revascularization

Chapter 22.   Stress Myocardial Perfusion Imaging in Patients with Diabetes Mellitus

Chapter 23.   Radionuclide Imaging in Heart Failure and Cardiomyopathies

Chapter 24.   Imaging in Patients Receiving Cardiotoxic Chemotherapy

Chapter 25.   Mechanistic and Methodologic Considerations for the Imaging of Mental Stress Ischemia

Chapter 26.   Measurement of Myocardial Blood Flow and Monitoring Therapy

Section VI:  Acute Coronary Syndromes

Chapter 27.   Imaging Patients with Chest Pain in the Emergency Department

Chapter 28.   Measuring the Efficacy of Therapy in Acute Myocardial Infarction with Technetium-99m-Sestamibi Imaging

Chapter 29.   Risk Stratification After Acute ST-Segment Elevation Myocardial Infarction

Chapter 30.   Risk Stratification in Acute Coronary Syndromes

Section VII:  Viability

Chapter 31.   Physiologic and Metabolic Basis of Myocardial Viability Imaging

Chapter 32.   Assessment of Myocardial Viability with Thallium 201 and Technetium-Based Agents

Chapter 33.   Assessment of Myocardial Viability with Positron Emission Tomography

Chapter 34.   Comparison with Non-Nuclear Techniques

Section VIII:  Tracer Specific Imaging Techniques

Chapter 35.   Fatty Acid Imaging

Chapter 36.   Cardiac Neurotransmission Imaging:  Single-Photon Emisison Computed Tomography

Chapter 37.   Cardiac Neurotransmission Imaging:  Positron Emission Tomography

Chapter 38.   Receptor Imaging

Section IX:  New Molecular Approaches

Chapter 39.   New Molecular Approaches for Imaging of Angiogenesis and Hypoxia

Chapter 40.   Noninvasive Detection of Cell Death in Myocardial Disorders

Chapter 41.   Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to Rupture

Chapter 42.   Molecular Imaging of Gene Products

Chapter 43.   Imaging Myocardial Inflammation

Case Examples for Use of Myocardial Perfusion Imaging

INDEX